Finance

Lists
VLA:VIE
Valneva SE
€2,65
0,00%
(0,00) 1D
6 Okt., 17:36:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VLA...
Open
€2,60
High
€2,65
Low
€2,60
Mkt. cap
482,62 m
Avg. vol.
1,24 k
Volume
1,03 k
52-wk high
€5,12
52-wk low
€2,05
EPS
-€0,89
Shares outstanding
90,92 m
No. of employees
620
Open
€2,60
High
€2,65
Low
€2,60
Mkt. cap
482,62 m
Avg. vol.
1,24 k
Volume
1,03 k
52-wk high
€5,12
52-wk low
€2,05
EPS
-€0,89
Shares outstanding
90,92 m
No. of employees
620
News stories
From web sources and news partners
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOThomas Lingelbach
Employees620
Founded2013
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
29,41 m
47,69 m
30,90 m
34,94 m
Cost of goods sold
51,19 m
61,64 m
41,40 m
48,36 m
Cost of revenue
51,19 m
61,64 m
41,40 m
48,36 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,80 m
16,54 m
15,14 m
13,77 m
Operating expense
15,56 m
13,73 m
13,20 m
12,75 m
Total operating expenses
66,76 m
75,37 m
54,60 m
61,11 m
Operating income
-37,35 m
-27,68 m
-23,70 m
-26,17 m
Other non operating income
-37,00 k
-
-
874,00 k
EBT including unusual items
-43,47 m
-51,08 m
-31,25 m
-31,77 m
EBT excluding unusual items
-43,70 m
-51,49 m
-31,25 m
-31,75 m
Income tax expense
882,00 k
-1,06 m
824,00 k
-566,00 k
Effective tax rate
-2,03%
2,08%
-2,64%
1,78%
Other operating expenses
-3,24 m
-2,81 m
-1,93 m
-1,02 m
Net income
-44,36 m
-50,02 m
-32,07 m
-31,20 m
Net profit margin
-150,82%
-104,89%
-103,78%
-89,31%
Earnings per share
-
-
-0,18
-0,17
Interest and investment income
845,00 k
-
526,00 k
-
Interest expense
-5,67 m
-24,71 m
-5,09 m
-5,54 m
Net interest expenses
-4,83 m
-24,71 m
-4,57 m
-5,54 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,96 m
-26,96 m
-19,46 m
-21,14 m
Gain or loss from assets sale
-230,00 k
432,00 k
-
14,00 k
AI content may include mistakes. Learn more
Google-programme